Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Sun Pharma Advanced Resea, Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Sun Pharma Advanced Resea

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

EOD Share Price97.75
Previous Share Price96.45
Price Change 1.30
Change % 1.35%
Volume585.77 K
Five Day Avg Vol796.78 K
Last Business Date01-Apr-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week 13.60 16.16
Two Weeks -1.35 -1.36
One Month -48.20 -33.03
Three Months -58.85 -37.58
Six Months -21.75 -18.20
One Year -96.15 -49.59

Highs / Lows

One Week104.085.6
Two Weeks106.881.0
One Month164.481.0
Three Months210.981.0
Six Months210.981.0
One Year210.981.0

Key Moving Average

5 Days 95.0494.804
15 Days 97.6067102.884
20 Days 109.69109.153
50 Days 149.842134.294
100 Days 157.487146.689
200 Days 148.818159.201
Detailed MA Analysis of SPARC ...

Key Technical Indicators

MACD -16.84
RSI 42.09
RSI (Smooth) 38.50
ADX 38.79
Chaikin Money Flow -0.050
Williams %R -58.64
PSAR 81.00
Detailed Tech Analysis SPARC ...

Financial Data Highlights

Market Cap2315.19
Book Value/ Share5.315
Enterprise Value-2873.31
Revenue TTM138.94
Gross Profit TTM165.54
Revenue /Share TTM5.31
Consensus Target525.00
Key Financial Highlights SPARC ...

Financial Ratios of SPARC

Div Yield0
Trailing PE0
Forward PE0
Key Financial Ratios of SPARC ...

Key Profit & Loss Data

Net Inc -145.43 26.18 %
Ops Income-152.12 39.34 %
Revenue182.87 133.67 %
Ops Expense334.99 1.81 %
PBT-145.43 26.18 %
Gross Profit165.54 247.92 %
Div Paid0 � %
Key P&L SPARC ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR7.157.31
Week PR17.8018.21
Month PR7.157.31
5 Day Period8.419.23
10 Day Period9.6310.88
5 Week Period28.7832.16
3 Months Period72.9273.01
Price Range /Volatility SPARC ...

Highlights & Chart Patterns of Sun Pharma Advanced Resea

Stock has jumped by more than 10% in last two weeks from its lowest level of 81.0 dt 25-Mar-20
Stock has jumped by more than 15% in last One Month from its lowest level of 81.0 dt 25-Mar-20.
Stock has fallen by more than 15% in last One Month from its highest level of 164.4 dt 05-Mar-20.
Stock has fallen by more than 25% in last three Month from its highest level of 210.9 dt 28-Jan-20.
Stock has fallen by more than 50% in last three Month from its highest level of 210.9 dt 28-Jan-20.
Stock has fallen to less than half in last One Year from its Highest level of 210.9 dt 28-Jan-20.
Bearish gap down Candlestick pattern was formed by Sun Pharma Advanced Resea on 30/03/2020
More Chart Patterns Sun Pharma Advanced Resea ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Sun Pharma Advanced Resea

Date Open High Low Close Volume
01-Apr-20 99.00 103.40 96.25 97.75 585 K
31-Mar-20 91.50 97.95 89.25 96.45 672 K
30-Mar-20 92.00 93.40 85.60 88.25 499 K
27-Mar-20 100.00 104.00 94.00 95.10 545 K
26-Mar-20 89.05 99.95 89.05 97.65 1681 K
25-Mar-20 81.00 86.00 81.00 84.15 378 K
24-Mar-20 92.80 94.20 82.15 83.30 424 K
23-Mar-20 93.00 99.05 86.10 87.10 482 K
20-Mar-20 95.40 106.80 94.65 104.55 1602 K
19-Mar-20 94.10 100.25 91.00 93.20 776 K
About Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. The company develops new chemical entities or reformulated products based on its proprietary novel drug delivery systems. Its core therapeutic areas of interest include oncology, inflammation, and neurodegenerative diseases, as well as abuse deterrent formulations. The company offers Levetiracetam ER for epilepsy; and Xelpros eye drops for Glaucoma. It is also developing Taclantis for the treatment of cancer; salmeterol-fluticasone dry powder inhaler for use in asthma and COPD; Baclofen GRS for spasticity; Brimonidine OD for glaucoma and ocular hypertension; and SDN-037 steroid eye drops used for the treatment of pain and inflammation following ocular surgery, and other inflammatory ocular conditions. In addition, the company engages in the development of SCO-088, a Bcr?Abl kinase inhibitor for treatment resistant chronic myelogenous leukaemia (CML); SDN-021, an abuse deterrent formulation; and SCD-044, a S1P receptor-1 agonist, which uses lymphocyte trafficking to treat auto-immune disorders. Further, it develops SCC?138 for Parkinson's disease; SDN?118, a formulation for treating depression; SDD-098 to treat acne; and SDE-124, a sub cutaneous injection of GLP-1 receptor agonists, as well as SCO-125 to treat CML. Sun Pharma Advanced Research Company Limited has a collaboration agreement with Bioprojet to develop S1P receptor 1 agonist for autoimmune disorders; and HitGen to identify small molecule leads for targets of interest. The company was incorporated in 2006 and is based in Mumbai, India. Sun Pharma Advanced Research Company Limited is a subsidiary of Shanghvi Finance Pvt. Ltd.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)

All Rights Reserved By Mintnovate Market Research Pvt Ltd.